Bio-Path Holdings, Inc.
BPTH
$0.03
-$0.01-19.53%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.03M | 2.03M | 2.80M | 3.90M | 4.55M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.39M | 8.33M | 10.92M | 13.06M | 11.54M |
| Operating Income | -5.39M | -8.33M | -10.92M | -13.06M | -11.54M |
| Income Before Tax | -6.09M | -8.67M | -11.18M | -12.32M | -9.59M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -6.09 | -8.67 | -11.18 | -12.32 | -9.59 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.09M | -8.67M | -11.18M | -12.32M | -9.59M |
| EBIT | -5.39M | -8.33M | -10.92M | -13.06M | -11.54M |
| EBITDA | -5.36M | -8.31M | -10.87M | -13.02M | -11.51M |
| EPS Basic | -0.73 | -1.10 | -1.71 | -2.30 | -2.90 |
| Normalized Basic EPS | -0.45 | -0.69 | -1.07 | -1.44 | -1.81 |
| EPS Diluted | -0.73 | -1.10 | -1.71 | -2.30 | -2.90 |
| Normalized Diluted EPS | -0.45 | -0.69 | -1.07 | -1.44 | -1.81 |
| Average Basic Shares Outstanding | 34.08M | 31.80M | 28.21M | 22.70M | 16.01M |
| Average Diluted Shares Outstanding | 34.08M | 31.80M | 28.21M | 22.70M | 16.01M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |